Until recently, Tropheryma whipplei was thought to be a rare bacterium typically causing the classic form of Whipple disease, which is characterized by histologic periodic acid-Schiff-stained bacilli in infected smallbowel macrophages [1, 2] . However, this well-known entity, described mainly in white men, represents only 1 rare clinical manifestation of T. whipplei infection. Indeed, recent studies have shown that the spectrum of infections due to T. whipplei is wide [1, [3] [4] [5] because this bacterium can cause localized infections, such as endocarditis, spondylodiskitis, meningoencephalitis, uve-itis, and pneumonia [1, 3, 4, [6] [7] [8] . The bacterium is also highly prevalent (15%) in fecal samples obtained from children aged 2-4 years in France who have gastroenteritis but was not detected in samples from a control group of children of the same age without diarrhea [9] . T. whipplei DNA has also been detected in stool and saliva specimens from asymptomatic individuals, but its prevalence depends on the geographic area [10, 11] . In Europe, the prevalence of this bacterium in fecal samples from the healthy general adult population is estimated to be 1%-11% [1] . In addition, the bacterium has been detected in sewage and is more prevalent in fecal samples of sewer workers (12%-26%) than in the general population [12] [13] [14] . In a recent study, 44% of children aged 2-10 years who live in rural Senegal carried T. whipplei in their stool samples [15] . Water from all 8 village wells have tested negative for T. whipplei by polymerase chain reaction (PCR) [15] . This research was part of a longitudinal study of the host-parasite relationship in 2 Senegalese villages, which was initiated in 1990 and focused initially on malaria and tickborne borreliosis [16, 17] . Improvements in the knowledge and management of these diseases have led us to extend our studies to look for other etiologic agents of fever. Because T. whipplei is highly prevalent in human stool samples obtained in rural Senegal and is also an agent of gastroenteritis [9] , we first hypothesized that T. whipplei gastroenteritis may correspond to a primo-infection and that there was bacteremia in patients who presented with fever [9] . Thus, our aim was to investigate the potential of T. whipplei to cause infection in patients with unknown fever and a negative test result for malaria in rural Senegal.
PATIENTS, MATERIALS, AND METHODS

Senegalese participants.
In 2008 and 2009, we performed studies among the population of Dielmo (13Њ43 N, 16Њ25 W) and Ndiop (14Њ33 N, 16Њ15 W), 2 villages in the Sine-Saloum region of Senegal, to assess the incidence of T. whipplei. These villages are included in the Dielmo project, a longitudinal prospective study initiated in 1990 for long-term investigation of host-parasite associations [16, 17] . In 2009, the survey showed a population of 391 in Dielmo (ratio of female to male subjects, 1.04:1), of which 35% were children younger than 10 years, and a population of 313 in Ndiop (ratio of female to male subjects, 1.1:1), of which 36.5% were children aged !10 years. At the beginning of the study, all members of the population, including patients and parents or legal guardians of all children, gave written individual informed consent. The national ethics committee of Senegal and the local ethic committee of the Institut Fédératif de Recherche 48 (Marseille, France) approved this study. Detection of individuals with fever was both passive and active. The dispensary created for the project was open 7 days a week. Every villager was also visited daily at home for clinical monitoring. For individuals with fever (defined as an axillary temperature 137.5ЊC), a medical attendant completed a medical examination and a thick blood film.
Blood analysis. Whole-blood samples were collected from finger pricks using a lancet stick and applied to glass microscope slides. Thick and thin blood smears were stained with Giemsa and analyzed by microscopy for trophozoites and gametocytes of malaria and Borrelia. If the malaria test result was negative, 200 mL (3-4 drops) of whole blood was collected for DNA extraction.
The first step of DNA extraction was done directly in the village dispensary using QIAamp kits (QIAGEN). The whole blood was digested with the supplied proteinase K. Then binding and washing of samples with Qiagen columns were performed with an adapted 35-mL PVC manual pump (Fisher Scientific). Next, the columns with the bound and dried DNA inside were stored at +4ЊC before final elution performed later at the Unite des Rickettsies, Marseille, France. After repeated washing with Buffer AW2 and incubation at room temperature for 5 min with 100 mL of Buffer AE, DNA was eluted by centrifugation at 6000g for 1 min.
Master mixtures were prepared by following the manufacturer's instructions. Quantitative real-time PCR was performed using a LightCycler instrument (Roche Diagnostics) with the QuantiTect Probe PCR Kit as described by the manufacturer. First, specimens were tested using the Twhi3F: 5 -TTGTGTA-TTTGGTATTAGATGAAACAG-3 and Twhi3R: 5 -CCCTACA-ATATGAAACAGCCTTTG-3 primer pair and the specific TaqMan probe Twhi3: 6-FAM-GGGATAGAGCAGGAGGTGT-CTGTCTGG-TAMRA, as previously reported [8] . When the specimen tested positive in this assay, the result was confirmed by a second quantitative PCR using the Twhi2F: 5 -TGAGGAT-GTATCTGTGTATGGGACA-3 and Twhi2R: 5 -TCCTGTTAC-AAGCAGTACAAAACAAA-3 primer set and the Twhi2 probe: 6-FAM-GAGAGATGGGGTGCAGGACAGGG-TAMRA. A case was defined as 2 positive quantitative PCR results in assays targeting 2 different T. whipplei repeated DNA sequences. The quality of DNA handling and extraction of blood samples was verified by quantitative PCR for a housekeeping gene coding for b-actin, as previously described [18] .
Stool and saliva analysis. In April 2009 we looked for T. whipplei in stool and saliva of the overall population, as previously done and reported in April 2008 [16] . We also sampled stool samples from patients when they developed diarrhea. After collection, each fecal specimen was mixed with 2.5 mL of absolute ethanol and each saliva specimen with 1 mL of absolute ethanol for storage and transportation to our laboratory at room temperature. On arrival, DNA was extracted using the BioRobot MDx workstation (Qiagen) in accordance with the manufacturer's recommendations and protocols. T. whipplei quantitative PCR assays were performed as described herein. A case was defined as 2 positive quantitative PCR results in assays targeting 2 different T. whipplei DNA sequences.
Blood control group. Ten blood specimens received in our laboratory for routine diagnostic purposes [19] sampled in an EDTA tube before DNA extraction and negative for T. whipplei were tested by quantitative PCR b-actin as previously described [18] . Data from 18 patients with chronic asymptomatic T. whipplei in the stool previously identified by our team [12] and followed up for 4 years by one of us (D.R.) in consultation were also included for comparisons. Sixty blood specimens sampled in EDTA tubes for 4 years from these 18 patients were tested for T. whipplei using quantitative PCR as previously described [19] .
Statistical analysis. Data were analyzed using EpiInfo software, version 3.4.1 (Centers for Disease Control and Prevention). Nonparametric values were compared using the x 2 test. Statistical significance was defined as P values !.05. The corrected x 2 test or the Fisher exact test was used when indicated. (Figures 1 and 2 ) tested positive for T. whipplei according to our criteria. Furthermore, the b-actin gene amplification by quantitative PCR was highly positive for all specimens, confirming the quality of the extracted DNA. Indeed, the mean number of cycles ‫ע(‬ standard deviation [SD]) of the cycles was 25 ‫ע‬ 2.85 for all of the blood specimens directly sampled for DNA extraction in Senegal and 26.19 ‫ע‬ -6.9 for 10 blood specimens received in our laboratory for routine diagnostic purposes and sampled in an EDTA tube before DNA extraction. The difference was not significant (P p .77) between these 2 ways of sampling.
RESULTS
Blood analysis.
The prevalence of T. whipplei-positive samples was 6.4% ( The main clinical characteristics of the patients who were positive for T. whipplei are summarized in Table 1 . Five patients were male and 7 were female. Patients were aged 7 months to 49 years, with a mean age (‫ע‬SD) of 10.7 ‫ע‬ 16.3 years, a median age of 3 years, and an interquartile range of 9 years. Their main clinical manifestations were cough (reported by 10 patients), thirst (8 patients), headache (7 patients), rhinorrhea (6 patients), fatigue (5 patients), sleep disorders (5 patients), and loss of appetite (3 patients). Only 1 patient presented with vomiting and 1 with diarrhea. All the patients were treated with acetominophen; only 1 received antibacterial therapy with trimethoprim-sulfamethoxazole. When compared with the 191 episodes without T. whipplei bacteremia, cough and sleep disorders are significantly more frequent in patients with T. whipplei DNA in their blood (P p .002 and P p .005, respectively) ( Table 2) .
Six patients presented with new episodes of fever after T. whipplei bacteremia, nearly 2 months later for 5 patients and 7 months later for 1 patient. Other blood specimens were also available. All T. whipplei PCR assay results were negative for 5 patients. For 1 patient, T. whipplei DNA was only slightly detected in 1 of the 2 specific PCR assays 2 months later; however, 7 months later both PCR assay results were negative. None of the blood specimens from the 18 French patients who were chronic asymptomatic carriers of T. whipplei were positive for T. whipplei.
Analysis of stool and saliva specimens. Of the 134 patients analyzed in this study, stool samples were also sampled for 86 at the time of systematic screening in Spring 2009, including 45 males and 41 females aged 7 months to 79 years (mean ‫ע‬ SD, 9 ‫ע‬ 13.3 years). The data are summarized in Table 3 . Among the 13 patients with T. whipplei bacteremia, stool samples were analyzed for 10 ( Figures 1 and 2 ). Among these 10 patients, 4 also had a positive PCR result in stool samples, whereas 6 had negative results. Twenty-five patients with negative T. whipplei PCR results in blood specimens had a positive stool T. whipplei PCR result at the time of the systematic screen- ing. Seventeen were from Dielmo and 8 from Ndiop. Fifty-one patients with negative T. whipplei PCR results in blood specimens also had a negative stool T. whipplei PCR result at the time of the systematic screening. Forty-two were from Dielmo and 9 from Ndiop. Overall, no significant differences were found between the presence of T. whipplei in stool samples at the time of the screening and T. whipplei bacteremia (P p .45). Table 4 . Among the 13 patients with T. whipplei bacteremia, saliva samples were analyzed for 7 patients from Dielmo. All test results were negative. Two patients from Ndiop with negative blood T. whipplei PCR results had a positive saliva T. whipplei PCR result at the time of the systematic screening. Forty-two patients with negative blood T. whipplei PCR results also had a negative saliva T. whipplei PCR result at the time of the systematic screening. Thirty-one were from Dielmo and 11 from Ndiop. No correlation was observed between T. whipplei infection and positive saliva T. whipplei PCR results at the time of the screening (P p .74).
DISCUSSION
We are embarking on a large program of identification of the bacterial agents causing fever in these 2 villages. We have already identified cases of rickettsioses [20] , Q fever [18] , and recurrent fever (unpublished data). To our knowledge, this study is the first attempt to investigate the presence of T. whipplei in blood specimens from patients with fever of uncertain origin. We detected T. whipplei DNA in 6.4% of blood samples from patients, primarily in children with fever in rural Senegal. We believe that our findings are reliable. The validity of the data reported herein is based on strict experimental procedures and controls, including rigorous positive and negative controls to validate the test. In addition, each positive PCR result was confirmed by the successful amplification of an additional DNA sequence.
In a previous study, we found that 44% of asymptomatic children aged 2-10 years who lived in rural Senegal carried T. whipplei in their stool samples [15] . This screening was performed in April 2008. Herein, we confirm these results and extent our data to the carriage of T. whipplei in saliva in older children and adults. The prevalence observed in individuals older than 10 years (18.2%) is lower than that in younger individuals but higher than that observed in Europe [12, 14] . In addition, this is the first time, to our knowledge, that T. whipplei in saliva has been detected in Senegal. The prevalence of salivary carriage of T. whipplei (4%) is lower than that in stool but is still higher than that previously observed in the general population in France (0.2%) and even in sewer workers (2.2%) [12, 19] . As in previous studies, the 2 individuals with a PCR-positive saliva specimen also harbored T. whipplei in stool samples [12, 19] .
Although a seasonal variation for the detection of T. whipplei DNA in blood specimens of patients with fever of uncertain origin cannot be determined, significantly more cases were diagnosed in the beginning of the dry season in December and January (P ! .001). Villagers from Dielmo had a significantly higher prevalence of T. whipplei bacteremia than those of Ndiop. Interestingly, malaria [16] , recurrent fever [17] , Q fever [18] , and fleaborne spotted fever [20] also had higher prevalences in Dielmo than in Ndiop. The significant differences of prevalence for these infectious diseases are commonly observed in neighboring places but currently remain unexplained. The main classic clinical manifestations linked to T. whipplei are arthralgia and diarrhea [1] , but T. whipplei has been reported to involve nearly all organs [1] . Our hypothesis at the beginning of this work was that primo-infection resulting in gastroenteritis and fever [9] may be associated with bacteremia. However, we were not able to link T. whipplei bacteremia to diarrhea or to the presence of T. whipplei in stool or saliva samples. However, our 2 screenings were performed in the spring, whereas most cases were observed in the winter.
Our work raises the question of the existence of a link between the presence of T. whipplei DNA in blood and the clinical manifestations of infection. Herein, the major clinical sign of our patients was fever associated with cough. T. whipplei has been recently suggested as an agent of pneumonia [7, 8] . The bacterium was detected in the bronchoalveolar lavage fluid of a child with pneumonia in the United States and in 6 (2.85%) of 210 bronchoalveolar lavage fluid samples collected in patients with pneumonia in intensive care units in France, including 1 case in which T. whipplei was the only bacterium detected [7, 8] . These overall data undoubtedly raise questions about the role of T. whipplei in the genesis of respiratory diseases without digestive involvement. It is currently difficult to locate this bacteremia in the natural cycle of T. whipplei infection. We propose several hypotheses (Figure 3) .
We did not test afebrile control subjects from Senegal, but the presence of T. whipplei DNA in blood samples from apparently healthy donors has been previously reported in a study with 1 positive sample of 174 (0.6%) [21] . In another study, of 913 blood specimens tested by T. whipplei PCR for patients with an excluded diagnosis of T. whipplei infection, none were positive [19] . We may suspect that asymptomatic T. whipplei bacteremia is more common in rural Senegal, where the bacterium is so common. This hypothesis should be addressed in the future because the lack of blood specimens from asymptomatic individuals in Dielmo and Ndiop is the main limitation of our study. However, the lack of bacteremia detected in French patients with chronic T. whipplei goes against this theory.
We confirm that children in rural Senegal are infected with T. whipplei at an early age. Our preliminary results suggest that T. whipplei may be associated with numerous undiagnosed infections with cough. We speculate that the distribution of T.
whipplei is widespread and that the bacterium is an agent of subtle, largely underestimated clinical manifestations, including respiratory infections.
